Table 3.
Overview of Included Studies
| Study (author, year of publication) | Study design | Disease process | Intervention or exposure | Setting (inpatient, outpatient, home, both, unknown) | No. of patients (control, experimental) | Outcome measured (HRU, EOLC, PRO, Survival) | Impact on outcome | |
|---|---|---|---|---|---|---|---|---|
| Studies with low risk of bias | Liver cancer | Hospice | Inpatient | 729 | 729 | HRU | Hospice care group had decreased total cost, number of procedures, ICU admissions. | |
| (Hwang et al., 2013)23 | Retrospective cohort | EOLC | Hospice care group had less CPR, defibrillation/cardioversion, and epinephrine injection. | |||||
| (Sanoff et al., 2017)25 | Retrospective cohort | HCC | Hospice | Unknown | 5056 | 2936 | HRU | Less likely to be hospitalized, have an ICU stay. |
| EOLC | Less likely to die in the hospital. | |||||||
| Studies with mod. risk of bias | Quality improvement | DC and HCC | Palliative care consultation | Outpatient | 30 | 30 | PRO | Improvement of symptom burden and depressive symptoms. |
| (Baumann et al., 2015)29 | ||||||||
| Studies with high risk of bias | Liver cancer | Hospice | Both | 644 | 206 | HRU | Hospice was associated with lower costs in the last month of life. | |
| (Chiang and Kao, 2015)28 | Retrospective cohort | Survival | No difference in survival between getting hospice and usual care. | |||||
| (Kao and Chiang 2015)24 | Retrospective cohort | Liver cancer | Hospice | Both | 462 | 2630 | EOLC | Hospice group with less CPR in the last month of life. |
| No difference in receiving chemotherapy in the last 2 weeks of life. | ||||||||
| Hospice group with fewer ICU admissions. | ||||||||
| HRU | Short-hospice group (<1 month) had more ER visits and hospital admissions. | |||||||
| (Lamba et al., 2012)30 | Prospective cohort, pre/post study | Pre and post-transplant liver disease in surgical ICU | Palliative care program | Inpatient | 79 | 104 | EOLC | Intervention showed an increase in goals of care conversations on physician rounds, increased DNR status, and increase in withdrawal of life support before death. |
| HRU | No difference in ICU or hospital LOS. | |||||||
| (Patel et al., 2017)26 | Retrospective cohort | DC and HCC | Palliative care encounter | Inpatient | 17,358 | 42,328 | HRU | Lower overall costs with palliative care. |
| (Riolfi et al. 2013)27 | Retrospective cohort | HCC | Palliative care service | Home | 11 | 15 | HRU | No difference in mean days in the hospital in last 2 months of life, mean number of hospitalizations in last 2 months of life. |
| EOLC | Patients who received palliative care at home, tended to die more at home. | |||||||
HCC, hepatocellular carcinoma; DC, decompensated cirrhosis; liver cancer, did not designate specifically HCC; LOS, lengths of stay; ICU, intensive care unit, HRU, healthcare resource utilization; EOLC, end-of-life care; PRO, patient-reported outcomes; CPR, cardiopulmonary resusciation; ER, emergency room; DNR, do-not-resuscitate.